Clinical Outcomes With Rivaroxaban in Patients Transitioned From Vitamin K Antagonist Therapy-Reference-Cited by-同舟云学术

Clinical Outcomes With Rivaroxaban in Patients Transitioned From Vitamin K Antagonist Therapy

Published:2013-06-18 Issue:12 Volume:158 Page:861
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Mahaffey Kenneth W.,Wojdyla Daniel,Hankey Graeme J.,White Harvey D.,Nessel Christopher C.,Piccini Jonathan P.,Patel Manesh R.,Berkowitz Scott D.,Becker Richard C.,Halperin Jonathan L.,Singer Daniel E.,Califf Robert M.,Fox Keith A.A.,Breithardt Günter,Hacke Werner

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a clinical decision support system to prevent anticoagulant duplications;International Journal of Medical Informatics;2024-07

2. Atrial fibrillation bleeding risk and prediction while treated with direct oral anticoagulants in warfarin‐naïve or warfarin‐experienced patients;Clinical Cardiology;2022-08-09

3. Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial;Open Heart;2022-02

4. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex;Circulation;2022-01-25

5. Using the Case-Crossover Design to Assess Short-Term Risks of Bleeding and Arterial Thromboembolism After Switching Between Oral Anticoagulants in a Population-Based Cohort of Patients With Atrial Fibrillation;American Journal of Epidemiology;2020-07-08